started · updated
Scientific research explores cancer resistance and immunotherapy biomarkers
Researchers have identified potential reasons why the heart remains largely protected from cancer development. A study from the University of Trieste suggests that the intense mechanical force generated by the heart, which contracts and expands up to 100,000 times daily, prevents tumor cells from establishing themselves.
Testing on genetically modified mice showed that when pumping frequency was reduced, cancer cells began to proliferate. However, normal pumping stimulates the production of a protein called Nesprin-2, which signals the nuclei of potential cancer cells to stop reproducing due to the unsuitable environment.
In a separate development, Brazilian researchers from Einstein Hospital and other centers have identified blood biomarkers that may predict how patients with Stage IV non-small cell lung cancer will respond to immunotherapy. While immunotherapy helps the immune system attack tumors, its effectiveness varies significantly between patients. This study aims to enable early identification of which patients are likely to benefit from the treatment, potentially improving survival rates for metastatic disease.
Entities
Einstein Hospital Israelita · Science · University of Trieste